NCT02606526View on ClinicalTrials.gov

Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda

PHASE3CompletedINTERVENTIONAL
Enrollment

4,500

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 21, 2024

Study Completion Date

June 21, 2024

Conditions
Severe IllnessSepticaemiaDiarrhoeaLower Respiratory Infection
Interventions
BIOLOGICAL

BCG at birth

See previous description

BIOLOGICAL

Control arm: Delayed BCG

See previous description

Trial Locations (1)

Unknown

Health Centers in Mukono and Kampala districts, Kampala

All Listed Sponsors
collaborator

University of Bergen

OTHER

collaborator

Radboud University Medical Center

OTHER

lead

Makerere University

OTHER

NCT02606526 - Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda | Biotech Hunter | Biotech Hunter